Testing Status of AZT + Pyrazinamide combination (AIDS Initiative) M930016
CASRN: AZTZINAMIDE
Secondary:
- 30516-87-1 - 3'-Azido-3'-deoxythymidine (AIDS)
- 30516-87-1 - AZT transplacental carcinogenesis study
- 98-96-4 - Pyrazinamide
Short-Term Toxicity
- 13 weeks (Gavage)
(C93003)
Completed
- Mice: B6C3F1
Organ Systems Toxicity
- 30 days Repro/Dev Gen Tox (28-Day) (Gavage)
(RDGT95001)
Completed
- NIH Number: 02-4408
Citation: NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Study of 3'-Azido-3'-deoxythymidine (AZT) and Pyrazinamide Combinations (CASRNs 30516-87-1 and 98-96-4) Administered by Gavage to Swiss (CD-1®) Mice - Male and Female Mice: Swiss
- Dose: Multiple.
- NIH Number: 02-4408